DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Oertel W, Eggert K, Pahwa R. et al.
Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinsonʼs disease (EASE LID 3).
Mov Disord 2017;
32: 1701-1709
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.